Ranitidine Capsule
Product Images NDC 27241-109

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ranitidine (NDC 27241-109). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ajanta Pharma Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ranitidine-150mg (Ranitidine 150mg)

Label for Ranitidine Capsules 150 mg by Ajanta Pharma USA Inc. The label indicates a package containing 60 capsules, with the NDC number 27241-109-06. It includes storage instructions and safety warnings, such as the package being child-resistant and storage temperature requirements. The label also displays the manufacturer location as Bridgewater, NJ, USA, with the product made in India.*

FDA Label Image

Ranitidine-300mg (Ranitidine 300mg)

Ranitidine 300 mg Capsules label showing 30 capsules per container. The label includes directions to store at 20°C to 25°C, a child-resistant package warning, and the labeler Ajanta Pharma USA Inc. It displays the NDC 27241-110-03 and features the Ajanta logo with a barcode on the right side.*

FDA Label Image

Structure (Ranitidine Structure)

Chemical structure of ranitidine, showing its molecular components including amine, nitro, and methyl groups, as well as a thioether linkage, consistent with the active ingredient ranitidine.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.